Literature DB >> 12133933

Cutting edge: molecular mechanisms of synergy between CD40 and the B cell antigen receptor: role for TNF receptor-associated factor 2 in receptor interaction.

Sokol A Haxhinasto1, Bruce S Hostager, Gail A Bishop.   

Abstract

Optimal Ag-specific B lymphocyte activation requires both recognition of Ag by the B cell Ag receptor (BCR) and contact-mediated interactions with Ag-specific Th lymphocytes. One of these interactions involves ligation of B cell CD40 by T cell-expressed CD154. CD40 signaling is crucial for Ab production, isotype switching, up-regulation of surface molecules, development of germinal centers, and the humoral memory response. The signaling pathways emanating from the BCR and CD40 are able to cooperate, but the molecular mechanisms responsible for this interaction are incompletely understood. The present study explored the roles of signaling motifs in the CD40 cytoplasmic tail in this synergy. We find that threonine in the PXQXT motif in the TNFR-associated factor-2 binding site is critical for synergistic effects of CD40 and BCR signals, independent of its phosphorylation. Furthermore, data suggest an indirect role for TNFR-associated factor-2 in the cooperative signaling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133933     DOI: 10.4049/jimmunol.169.3.1145

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

Review 2.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1.

Authors:  John P Graham; Carissa R Moore; Gail A Bishop
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

4.  The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.

Authors:  Pradeep Bangalore-Prakash; Laura L Stunz; Nurbek Mambetsariev; Amy L Whillock; Bruce S Hostager; Gail A Bishop
Journal:  Blood Adv       Date:  2017-12-18

5.  Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes.

Authors:  Ping Xie; Jayakumar Poovassery; Laura L Stunz; Sonja M Smith; Mark L Schultz; Lindsey E Carlin; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2011-10-04       Impact factor: 4.962

6.  TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.

Authors:  Julia Hauer; Stephanie Püschner; Parameswaran Ramakrishnan; Ute Simon; Martina Bongers; Christine Federle; Hartmut Engelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-11       Impact factor: 11.205

7.  A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling.

Authors:  Joanne M Hildebrand; Zhenghua Luo; Michelle K Manske; Tammy Price-Troska; Steven C Ziesmer; Wai Lin; Bruce S Hostager; Susan L Slager; Thomas E Witzig; Stephen M Ansell; James R Cerhan; Gail A Bishop; Anne J Novak
Journal:  J Exp Med       Date:  2010-11-01       Impact factor: 14.307

8.  Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.

Authors:  Jose-Andres C Portillo; Jennifer A Greene; Isaac Schwartz; Maria Cecilia Subauste; Carlos S Subauste
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

Review 9.  Multiple roles of TRAF3 signaling in lymphocyte function.

Authors:  Gail A Bishop; Ping Xie
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

10.  A novel polymorphism of the human CD40 receptor with enhanced function.

Authors:  Anna L Peters; Robert M Plenge; Robert R Graham; David M Altshuler; Kathy L Moser; Patrick M Gaffney; Gail A Bishop
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.